On Monday, November 18th, six extraordinary members of our Crothall Environmental Services team proudly represented us as the “Cleaning Crusaders” at the 2024 IEHA Housekeeping Olympics in Las Vegas, Nevada. This prestigious event transforms cleaning into an Olympic sport, drawing top teams from around the globe. While traditionally aimed at the hospitality industry, the competition…
In this episode, we’re joined by Emily Lindemer, an executive director at Morgan Health. Lindemer discusses a recent report she co-authored, which focuses on maternal health opportunities in employer-sponsored insurance. The post MedCity FemFwd: Comparing Maternal Health in Employer-Sponsored Populations vs. Medicaid appeared first on MedCity News.
More effective and proactive care requires a framework that will enable the U.S. healthcare system to better meet the inevitable challenges of an aging population and pave the way for a sustainable and equitable future. Monitoring and other digital health enabled tools are helping to build that framework by offering a new medium for care…
We are living in a moment when many realize that collaboration yields better, faster and more affordable advances. Open source also enables the potential for bigger profits and revenue. What’s in reach: a small amount of money paid for treatments across millions of people, rather than expensive lifesaving treatments only for the few who can…
Vertex Pharmaceuticals’ Jounavx is now FDA approved, providing patients a non-opioid option for treating acute pain. The twice-daily pill is the first in a new class of medicines that block a key pathway in the peripheral nervous system. The post Vertex Pharma’s Opioid Alternative Wins FDA Approval, First in a New Class of Pain Meds…
Hone Health’s Series A round included participation from Tribe Capital, PIF, Republic Capital, Vibe VC, Humbition, Hanwha, Gaingels, Looking Glass Capital, FJ Labs and Agent Capital. In total, the company has raised $39 million. The post Telehealth Clinic Hone Health Secures $33M, Acquires Home Health Company appeared first on MedCity News.
Phase 2 data for Cargo Therapeutics’ CD22-targeting cell therapy show low durability and cases of a severe immune response, some that were classified as grade 4 or 5 serious adverse events. Cargo is discontinuing the study and shifting focus to a different cell therapy on track to begin Phase 1 testing in mid-2025. The post…
As the pool of approved therapies continues to (hopefully) expand, the clinical and diagnostic testing communities need to do a better job at ensuring the right patients move through this journey more quickly – and accurately – to improve their health and prognosis. The post Why Blood is Best: Transforming the Diagnostic Journey for Alzheimer’s…
By insisting on coding-aware AI solutions, health systems can ensure that these technologies fulfill their transformative promise, reducing clinician burnout and administrative burden, improving patient care and communication, and accurately capturing what occurred during an encounter. The post The Most Overlooked Feature with AI Scribes: Coding Awareness appeared first on MedCity News.
Infectious disease is the focus of the biopharma track at INVEST Pitch Perfect May 20-21 in Chicago. Register today! The post A Snapshot of Five Contenders to Combat Infectious Diseases in the Post-Pandemic Landscape appeared first on MedCity News.